IC
ZBH icon

Inscription Capital’s Zimmer Biomet ZBH Stock Holding History

Inscription Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Buy
+2,970
New +$260K 0.02% 602

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Inscription Capital's ZBH Position: Q2 2026 in Review

Inscription Capital opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 2,970 shares worth $256K. The stake represents 0.02% of the portfolio and ranks #602 among its holdings.

906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Inscription Capital held 2,970 shares of Zimmer Biomet worth $256K as of Q2 2026.
  • Zimmer Biomet was a new Inscription Capital position in Q2 2026.
  • Zimmer Biomet made up 0.02% of Inscription Capital's portfolio in Q2 2026, its #602 holding.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.